The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system

Neuropsychopharmacology

Volumn 24, Issue 5, 2001, Pages 467-477

  Mann, J John ^a,c   Brent, David A ^b   Arango, Victoria ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Box 42 ^*  (United States)

Author keywords

Candidate genes; Neuro receptors; Serotonin; Suicide; Suicide attempt

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; GENE PRODUCT; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

AGGRESSION; CONTROLLED STUDY; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; HERITABILITY; HUMAN; IMPULSIVENESS; MENTAL DISEASE; NEUROBIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REVIEW; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CARRIER PROTEINS; DEPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE; TRYPTOPHAN HYDROXYLASE;

EID: 0035078362     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00228-1     Document Type: Review

References (140)

1. Suicidal behaviors and the tryptophan hydroxylase gene
2. 1D sites is reduced in prefrontal cortex of alcoholics
3. Relevance of serotonergic postmortem studies to suicidal behavior
4. Serotonin chemistry in the brain of suicide victims
5. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims
6. Postmortem findings in suicide victims: Implications for in vivo imaging studies
7. Serotonergic split brain and suicide
8. Reversed hemispheric asymmetry of imipramine binding in suicide victims
9. 3H-imipramine binding in the frontal cortex of suicides
10. 3H-imipramine binding: Studies in the frontal cortex of normal controls and suicide victims
11. 2 receptors in suicide victims
12. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness
13. 5-Hydroxytryptamine metabolites in affective illness: The effect of tryptophan administration
14. CSF monoamine metabolites in melancholia
15. Therapeutic effects of serotonin uptake inhibitors in depression
16. Cerebrospinal fluid studies in suicide. An overview
17. The serotonin transporter gene and peer-rated neuroticism
18. Alcohol and central serotonin metabolism in man
19. Factor analysis of some psychometric measures of impulsiveness and anxiety
20. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes
21. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims
22. Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables
23. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A
24. X-linked borderline mental retardation with prominent behavioral disturbance: Phenotype, genetic localization, and evidence for disturbed monoamine metabolism
25. Association between suicide attempt and the trytophane hydroxylase (TPH) gene
26. Urinary free cortisol excretion in depression
27. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
28. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior
29. Effect of amitriptyline on endocrine responses to intravenous L-tryptophan
30. 1B serotonin receptors
31. Genetics of mouse behavior: Interactions with laboratory environment
32. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides
33. The return of Phineas Gage: Clues about the brain from the skull of a famous patient
34. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
35. A human serotonin 1D receptor variant (5HT1Dβ) encoded by an intronless gene on chromosome 6
36. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder
37. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims
38. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance
39. Suicide and family loading for affective disorders
40. Recovery from major depression is not associated with normalization of serotonergic function
41. Early onset substance abuse and community violence by outpatients with chronic mental illness
42. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects
43. CSF Neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls
44. Genetics
45. Genetic studies of affective illness
46. Catecholamine metabolite studies in the affective disorders: Issues of specificity and significance
47. Autoradiographic analysis of tritiated imipramine binding in the human brain postmortem: Effects of suicide
48. 1D-type serotonin receptor
49. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects
50. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females
51. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys
52. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta)
53. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain
54. 2 sites in cortex and amygdala
55. 1B genotype and receptor binding kinetics in postmortem brain tissue
56. Functional difference in monoamine transmitters in the behaviorally abnormal mouse mutant (wriggle mouse sagami)
57. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: Relationships to monoamine metabolite concentrations in CSF of healthy volunteers
58. 1A binding in dorsal and median raphe nuclei of suicide victims
59. CSF and urinary biogenic amines and metabolism in depression and mania. A controlled univariate analysis
60. 2 receptor binding and 5-HT transporter mRNA expression in rat brain
61. 3H]imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine
62. 1Dβ autoreceptor gene on chromosome 6 and direct analysis for sequence variants
63. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in two populations
64. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study
65. 3H]paroxetine binding, a marker of serotonin-uptake sites
66. 3H]paroxetine, in antidepressant-free depressed suicides
67. 3H-paroxetine binding sites in post-mortem human brain from controls and suicides
68. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
69. 1D subtype
70. 1D binding in globus pallidus but not cortex
71. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computer tomography
72. Serotonin and major depression
73. Violence and aggression
74. The neurobiology of suicide
75. Evidence for the 5-HT hypothesis of suicide: A review of post-mortem studies
76. 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high-affinity, nontransporter sites
77. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients
78. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients
79. Towards a clinical model of suicidal behavior in psychiatric patients
80. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene
81. A regulatory polymorphism of the monoamine oxidase-A gene maybe associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity
82. Receptors for 5-hydroxytryptamine: Current perspectives on classification and nomenclature
83. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients
84. Human brain receptor alterations in suicide victims
85. Inhibition of mouse killing behavior by serotonin-mimetic drugs: Effects of partial alterations of serotonin neurotransmission
86. 1A receptor: Glycine 22 to serine 22 and isoleucine 28 to valine 28
87. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism
88. A tryptophan hydroxylase gene marker for suicidality and alcoholism
89. CSF 5-HIAA predicts suicide risk after attempted suicide
90. Identification of genetic variation in the human serotonin 1Dβ receptor gene
91. Prolactin and cortisol responses to d-fenfluramine in major depression: Evidence for diminished responsivity of central serotonergic function
92. Serotonergic mechanisms in brains of suicide victims
93. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter
94. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies
95. High-affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet; studies in depression
96. Decreased imipramine binding in the brains of patients with depressive illness
97. Brain research mechanisms and symptom formation. Estimation of brain amine metabolism in affective illness: Cerebrospinal fluid studies utilizing probenecid
98. Serotonin function and depression: Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects
99. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
100. 1B receptor knock out - Behavioral consequences
101. Cerebrospinal fluid amine metabolites
102. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor
103. Genetics of suicide
104. Genetic and biologic risk factors for suicide in depressive disorders
105. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study
106. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
107. Suicide in twins
108. Attempted suicide among living co-twins of twin suicide victims
109. A functional polymorphism in the monoamine oxidase A gene promoter
110. Cortisol production in depressive illness
111. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence
112. 1B receptor
113. Genetics of alcoholism
114. α6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study
115. A family study of suicide
116. The domain of supervisory processes and temporal organization of behaviour
117. Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients
118. 1Dβ) not linked to schizophrenia in five Canadian pedigrees
119. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression
120. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis
121. Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in brain
122. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides
123. Suicidal behaviour: An epidemiological and genetic study
124. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - Post-mortem evidence for decrease serotonin activity
125. Gene mapping in the 20th and 21st centuries: Statistical methods, data analysis, and experimental design
126. Prediction of suicidal behavior from biologic tests
127. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide
128. Blunted growth hormone and prolactin responses to L-tryptophan in depression; A state-dependent abnormality
129. Central serotonin metabolism and frequency of depression
130. Parachlorophenylalanine-induced serotonin depletion increases offensive but not defensive aggression male rats
131. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers
132. 1Dβ
133. Hostility and depression associated with suicide attempts
134. 1A receptor gene
135. 1A receptor is intact in mood disorders
136. 2A receptor gene polymorphism in mood disorders